Diminished oxygen availability, termed hypoxia, within solid tumors is one of the most common characteristics of cancer. Hypoxia shapes the landscape of the tumor …
JA Losman, P Koivunen, WG Kaelin Jr - Nature Reviews Cancer, 2020 - nature.com
Oxoglutarate-dependent dioxygenases (2OGDDs) are a superfamily of enzymes that play diverse roles in many biological processes, including regulation of hypoxia-inducible factor …
K Joshi, S Liu, P Breslin SJ, J Zhang - Cellular and Molecular Life Sciences, 2022 - Springer
The ten–eleven translocation (TET) family of dioxygenases consists of three members, TET1, TET2, and TET3. All three TET enzymes have Fe+ 2 and α-ketoglutarate (α-KG) …
Y Xu, Y Yang, Z Wang, M Sjöström, Y Jiang… - Cancer …, 2024 - aacrjournals.org
Cancer cells exhibit phenotypical plasticity and epigenetic reprogramming that allows them to evade lineage-dependent targeted treatments by adopting lineage plasticity. The …
The mechanisms governing the methylome profile of tumor suppressors and oncogenes have expanded with the discovery of oxidized states of 5-methylcytosine (5mC). Ten-eleven …
A Kumaraswamy, KRW Leng, TC Westbrook, JA Yates… - European urology, 2021 - Elsevier
Context In addition to genetic alterations, epigenetic alterations play a crucial role during prostate cancer progression. A better understanding of the epigenetic factors that promote …
J Gandhi, A Afridi, S Vatsia, G Joshi, G Joshi… - Prostate cancer and …, 2018 - nature.com
Background With continuous progress over the past few decades in understanding diagnosis, treatment, and genetics, much has been learned about the prostate cancer …
V Conteduca, J Hess, Y Yamada, SY Ku… - … andrology and urology, 2021 - ncbi.nlm.nih.gov
Epigenetic alterations, including changes in DNA methylation, histone modifications and nucleosome remodeling, result in abnormal gene expression patterns that contribute to …
To identify cancer-associated gene regulatory changes, we generated single-cell chromatin accessibility landscapes across eight tumor types as part of The Cancer Genome Atlas …